• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2000014 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-09-16 view
JXSB2000015 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2020-09-16 view
JXSB2100016 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-02-27 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-02-26 view
JXSB2100023 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2100024 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2100025 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-03-20 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company In Review 2021-03-19 view
JXSB2101032 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-07-13 Eli Lilly & Company view
JXSB2101033 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-07-13 Eli Lilly & Company view
JXSB2101034 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-07-13 Eli Lilly & Company view
JXSB2101069 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-10-21 Eli Lilly & Company view
JXSB2101070 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-10-21 Eli Lilly & Company view
JXSB2101109 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-12-16 Eli Lilly & Company view
JXSB2101110 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-12-16 Eli Lilly & Company view
JXSB2101111 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2021-12-16 Eli Lilly & Company view
JXSB2200082 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-06-20 Eli Lilly & Company view
JXSB2200083 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-06-20 Eli Lilly & Company view
JXSB2200084 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-06-20 Eli Lilly & Company view
JXSB2200108 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-09-06 Eli Lilly & Company view
JXSB2200109 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-09-06 Eli Lilly & Company view
JXSB2200110 Mirikizumab注射液 mirikizumab Injection Biological Products(1) Supplementary Application 2022-09-06 Eli Lilly & Company view